Related Experiment Video
Updated: Dec 9, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Increased red blood cell distribution width might predict left ventricular hypertrophy in patients with atrial
Hui-Ming Yao1, Xiao-Lei Wang2, Xiong Peng1
1Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanchang University.
Insights
Red blood cell distribution width is linked to left ventricular hypertrophy in atrial fibrillation patients. Higher red blood cell distribution width indicates increased risk, while lower low-density lipoprotein and ejection fraction show protective associations.
Area of Science:
- Cardiology
- Internal Medicine
- Clinical Research
Background:
- Left ventricular hypertrophy (LVH) is an independent risk factor for stroke and death in patients with atrial fibrillation (AF).
- Identifying risk factors for LVH in AF patients is crucial for risk stratification and management.
- Previous studies have not fully elucidated the specific predictors of LVH in this population.
Purpose of the Study:
- To investigate the potential risk factors associated with left ventricular hypertrophy in patients diagnosed with atrial fibrillation.
- To determine the predictive value of identified risk factors for LVH in AF patients.
Main Methods:
- Retrospective analysis of clinical data from 87 consecutive patients with atrial fibrillation.
- Multivariate logistic regression to identify independent risk factors for LVH.
- Receiver operating characteristic (ROC) curve analysis to determine cut-off values, sensitivity, and specificity of predictors.
Main Results:
- Red blood cell distribution width (RDW) was identified as an independent risk factor for LVH (OR 4.89, P<0.05).
- Low-density lipoprotein (LDL) concentration (OR 0.37, P<0.05) and left ventricular ejection fraction (LVEF) (OR 0.88, P<0.05) were inversely associated with LVH.
- ROC analysis showed an area under the curve of 0.80 for RDW, with a cut-off of 13.05, sensitivity of 72.1%, and specificity of 76.9% in predicting LVH.
Conclusions:
- Red blood cell distribution width is significantly associated with left ventricular hypertrophy in patients with atrial fibrillation.
- RDW may serve as a valuable biomarker for predicting LVH in AF patients.
- Further prospective studies are warranted to confirm these findings and explore therapeutic implications.
Abstract:
The presence of left ventricular hypertrophy has been confirmed to be an independent risk factor for stroke and death in patients with atrial fibrillation. This retrospective study aimed to evaluate the potential risk factors for left ventricular hypertrophy in patients with atrial fibrillation.A series of consecutive patients diagnosed with atrial fibrillation between June 2018 and December 2019 were included. The patients' clinical data were analyzed. The cut-off values, sensitivity and specificity of the independent risk factors were calculated using a receiver operating characteristic curve.Among 87 patients with atrial fibrillation, 39 patients with left ventricular hypertrophy and 48 patients without left ventricular hypertrophy were included. Multivariate logistic regression analysis showed that red blood cell distribution width (odds ratio [OR] 4.89, 95% confidence interval [CI]: 1.69-14.13, P < .05) was an independent risk factor, while the concentration of low-density lipoprotein (OR 0.37, 95% CI: 0.17-0.83, P < .05) and left ventricular ejection fraction (OR 0.88, 95% CI: 0.82-0.95, P < .05) were inversely associated with left ventricular hypertrophy in atrial fibrillation patients. The receiver operating characteristic curve demonstrated that the area under the curve was 0.80 (95% CI: 0.71-0.90, P < .05) with a cut-off value of 13.05, and the red blood cell distribution width predicted left ventricular hypertrophy status among atrial fibrillation patients with a sensitivity of 72.1% and a specificity of 76.9%.Red blood cell distribution width was associated with left ventricular hypertrophy in patients with atrial fibrillation.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Heart Failure II: Pathophysiology

